USPTO serial 99791407
MYOSITIS COLLAB
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- BODRI, KRISTIN MARIE
- Law office
- TMEG LAW OFFICE 105
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with MYOSITIS COLLAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Zwijnaarde, BE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Edward T. White
Edward T. White Williams Mullen200 South 10th Streetc/o IP DocketRichmond, VA 23219Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable mobile applications, namely mobile applications for a digital platform to record, store, evaluate, analyse and provide reports on patients' experiences of autoimmune diseases and treatments; providing downloadable software to record, store, evaluate, analyse and provide reports on patients' experiences of autoimmune diseases and treatments; downloadable electronic publications to promote public awareness of medical conditions namely autoimmune diseases; electronic publications featuring medical information and patient support in the field of autoimmune diseases | ACTIVE | — |
| 035 | Provision of patient information, namely, providing medical information relating to autoimmune diseases and treatments through an online computer network; advertising services to promote public awareness of medical conditions, namely autoimmune diseases; advertising and promotional services to promote awareness of patient support offerings in the field of autoimmune diseases; Dissemination of advertising and promotional material, leaflets and printed matter to promote public awareness of medical conditions, namely, autoimmune diseases; dissemination of advertising and promotional material, leaflets and printed matter featuring medical information and patient support in the field of autoimmune diseases | ACTIVE | — |
| 041 | Conducting and organizing of seminars and conferences in the field of medical science, namely, in the field of autoimmune diseases; medical education services in the field of autoimmune diseases; conducting education support programmes for patients in the field of autoimmune diseases; conducting educational events for patients and healthcare professionals in the field of autoimmune diseases; educational services, namely, conducting educational programs in the fields of clinical trials, pharmaceuticals, medical disorders, namely autoimmune diseases and their treatment, and patient support options for these conditions; providing electronic publications to promote public awareness of medical conditions, namely autoimmune diseases; providing electronic publications featuring medical information and patient support in the field of autoimmune diseases | ACTIVE | — |
| 044 | Medical information services in the field of autoimmune diseases; providing medical information in the healthcare sector in the field of autoimmune diseases; medical advisory services in the field of autoimmune diseases; providing health information in the field of autoimmune diseases; providing health information to patients, caregivers and health care professionals in the field of autoimmune diseases; providing health care information in the field of autoimmune diseases; providing patient support services relating to medications in the field of autoimmune diseases; Providing information to patients in the field of medical diseases, namely autoimmune diseases and the treatment thereof; medical consultancy and medical information services relating to pharmaceuticals, medical conditions, namely, autoimmune diseases and their treatment; advisory services relating to medical conditions, namely, autoimmune diseases and the treatments thereof; providing medical information in the field of autoimmune diseases via a website; providing medical information, consultancy and advisory services in the field of autoimmune diseases; providing information over a global computer network in the field of health care, namely, autoimmune diseases; providing medical information in the field of clinical trials, pharmaceuticals, medical disorders, namely autoimmune diseases and their treatment; provision of patient information, namely, providing medical information relating to diseases and treatments, namely in the field of autoimmune diseases, through an online computer network | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Argenx B.V.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named MYOSITIS COLLAB
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 15, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 9, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 8, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 8, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 28, 2026 | NWAP | NEW APPLICATION ENTERED | — |
| Apr 28, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |